Levation Pharma Initiates Phase I/II Clinical Trial of LEV102 for Acquired Blepharoptosis
February 27, 2023 08:00 ET
|
Levation Pharma
LOS ANGELES, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Levation Pharma Ltd., a pharmaceutical company focused on the development of new therapeutics for the ophthalmology and aesthetic space, received FDA...